(Updated - December 8, 2020 2:00 AM EST)(updating comment)Citi analyst Yigal Nochomovitz upgraded Lexicon Pharmaceuticals (NASDAQ: LXRX) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE